Circumstantial evidence for increased potassium conductance of membrane of cardiac muscle by 2-nicotinamidoethyl nitrate (SG-75)
- PMID: 161336
- DOI: 10.1254/jjp.29.687
Circumstantial evidence for increased potassium conductance of membrane of cardiac muscle by 2-nicotinamidoethyl nitrate (SG-75)
Abstract
The mechanism of action of 2-nicotinamidoethyl nitrate (SG-75), was investigated by the use of arterially blood-perfused papillary muscle preparations of the dog. All drugs were administered intra-arterially. SG-75 shortened the effective refractory period (ERP) and decreased the rate of automaticity and developed tension of the papillary muscle, whereas verapamil failed to change the ERP despite a decrease in the developed tension. SG-75 in extremely high doses induced ventricular fibrillation. Methacholine produced decreases in the rate of automaticity and developed tension, and the actions were abolished by atropine. The SG-75-induced decreases in two parameters were not modified by atropine. These results indicate that the cardiac action of SG-75 differs from that of calcium-antagonistic vasodilators and it is suggested that the basic mechanism of action of SG-75 involves an increase in potassium conductance in the membrane of cardiac muscle, without mediation through muscarinic receptors.
Similar articles
-
Effect of 2-nicotinamidethyl nitrate (SG-75) on the membrane potential of left atrial muscle fibres of the dog. Increase in potassium conductance.Naunyn Schmiedebergs Arch Pharmacol. 1980 May;312(1):69-76. doi: 10.1007/BF00502577. Naunyn Schmiedebergs Arch Pharmacol. 1980. PMID: 6446686 No abstract available.
-
Differential chronotropic and inotropic effects of 2-nicotinamidoethyl nitrate (SG-75) in the dog isolated atrium.Clin Exp Pharmacol Physiol. 1980 Mar-Apr;7(2):205-8. doi: 10.1111/j.1440-1681.1980.tb00062.x. Clin Exp Pharmacol Physiol. 1980. PMID: 6445800
-
Pharmacological profile of a new coronary vasodilator drug, 2-nicotinamidoethyl nitrate (SG-75).Clin Exp Pharmacol Physiol. 1979 May-Jun;6(3):301-16. doi: 10.1111/j.1440-1681.1979.tb01252.x. Clin Exp Pharmacol Physiol. 1979. PMID: 157241
-
Nicorandil as a hybrid between nitrates and potassium channel activators.Am J Cardiol. 1989 Jun 20;63(21):18J-24J. doi: 10.1016/0002-9149(89)90200-2. Am J Cardiol. 1989. PMID: 2525320 Review.
-
Similarity and dissimilarity in the mode and mechanism of action between nicorandil and classical nitrates: an overview.J Cardiovasc Pharmacol. 1987;10 Suppl 8:S1-9. J Cardiovasc Pharmacol. 1987. PMID: 2447414 Review.
Cited by
-
Electrophysiologic effects of potassium channel openers.Cardiovasc Drugs Ther. 1995 Mar;9 Suppl 2:195-202. doi: 10.1007/BF00878466. Cardiovasc Drugs Ther. 1995. PMID: 7647023 Review.
-
Coronary effects of nicorandil in comparison with nitroglycerin in chronic conscious dogs.Cardiovasc Drugs Ther. 1991 Feb;5(1):131-8. doi: 10.1007/BF03029808. Cardiovasc Drugs Ther. 1991. PMID: 1827988
-
Interaction of potassium channel openers and blockers in canine atrial muscle.Br J Pharmacol. 1989 Jul;97(3):753-62. doi: 10.1111/j.1476-5381.1989.tb12013.x. Br J Pharmacol. 1989. PMID: 2527073 Free PMC article.
-
Nicorandil and cardiovascular performance in anaesthetized pigs with a concentric coronary artery stenosis.Naunyn Schmiedebergs Arch Pharmacol. 1989 Dec;340(6 Pt 2):733-9. doi: 10.1007/BF00169682. Naunyn Schmiedebergs Arch Pharmacol. 1989. PMID: 2534490
-
Accelerated myocardial metabolic and functional recovery with terminal nicorandil-Mg cardioplegia in heart transplantation.Cardiovasc Drugs Ther. 1991 Aug;5(4):727-32. doi: 10.1007/BF03029747. Cardiovasc Drugs Ther. 1991. PMID: 1832290
MeSH terms
Substances
LinkOut - more resources
Full Text Sources